A Phase 1 Study to Evaluate the Potential Drug Interactions Between ALXN2080 and Itraconazole, Fluconazole, and Carbamazepine in Healthy Adult Participants
Latest Information Update: 24 Jun 2024
Price :
$35 *
At a glance
- Drugs ALXN-2080 (Primary) ; Carbamazepine; Fluconazole; Itraconazole
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Alexion AstraZeneca Rare Disease
- 17 Jun 2024 Status changed from recruiting to completed.
- 05 Mar 2024 Planned End Date changed from 10 Apr 2024 to 6 May 2024.
- 05 Mar 2024 Planned primary completion date changed from 10 Apr 2024 to 6 May 2024.